ArticleBMJ open2026

Estimating the carbon footprint of oral semaglutide (Rybelsus): a comparative analysis of the medicine carbon footprint model and manufacturer life-cycle assessment in pharmaceutical production.

Louise Hansell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.